1. Zannis VI, Kypreos KE, Chroni A, Kardassis D, Zanni EE. (2004) Lipoproteins and atherogenesis. In: Molecular Mechanisms of Atherosclerosis. Loscalzo J (ed). Taylor & Francis, New York, NY, pp. 111–74.
2. Herbert PN, Assmann G, Gotto AM Jr, Fredrickson DS. (1982) Familial lipoprotein deficiency: alpha beta lipoproteinemia, hypobetalipoproteinemia, and Tangier disease. In: The Metabolic Basis of Inherited Disease. Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, and Brown MS (eds.). McGraw-Hill, New York, pp. 589–651.
3. Brunham LR, et al. (2006) Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116:1052–62.
4. Timmins JM, et al. (2005) Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J. Clin. Invest. 115:1333–42
5. Fielding CJ, Shore VG, Fielding PE. (1972) A protein cofactor of lecithin:cholesterol acyltransferase. Biochem. Biophys. Res. Commun. 46:1493–8.